Federated learning trains a shared model across decentralized pharmaceutical datasets without moving the underlying data from the organizations that hold it. It addresses proprietary data silos containing compounds synthesized, measured properties, clinical trials, and negative results. section 13.4.3
A practical deployment must address:
- Model convergence: distributed training may fail to converge reliably across organizations. section 13.4.3
- Information leakage: sharing model updates can expose information despite keeping source datasets private. section 13.4.3
- Data imbalance: private datasets may contain inactive compounds, toxicity results, or other negative outcomes missing from public collections. section 13.4.3

